Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page was published. This update may involve minor content or formatting adjustments but does not indicate substantive changes to study data or eligibility.
    Difference
    0.1%
    Check dated 2026-07-25T12:32:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record now includes Melanoma as an additional relevant term and lists MedlinePlus Genetics under related topics. This improves indexing and cross-referencing for users exploring melanoma-related information.
    Difference
    0.2%
    Check dated 2026-07-18T08:42:33.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The study's related topics section loses three items: Melanoma, related topics:, and MedlinePlus Genetics, removing these terms from the MeSH/related topics listing for the record.
    Difference
    0.2%
    Check dated 2026-07-11T03:15:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The study record revision was updated from v3.6.2 to v3.6.3, indicating a new edition of the page that likely includes small corrections.
    Difference
    0.1%
    Check dated 2026-07-04T01:04:52.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page adds related topics Melanoma and MedlinePlus Genetics and updates the revision to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-26T22:50:30.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's disease label 'Melanoma' and the related topics section including 'MedlinePlus Genetics' were removed, reducing visible disease context and related information links.
    Difference
    0.2%
    Check dated 2026-06-19T17:49:42.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.